FDA Adverse Event Malfunction Summary report: N

INFINITI VISION SYSTEM OZIL

MDR report key: 2042966 · Received February 23, 2011

Report

Report Number
2028159-2011-00162
Event Type
Malfunction
Date Received
February 23, 2011
Date of Event
January 10, 2011
Report Date
January 24, 2011
Manufacturer
ALCON - IRVINE TECHNOLOGY CENTER
Product Code
HQC
PMA / PMN Number
K082845
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A COMPANY REP EXAMINED THE SYSTEM AND CONFIRMED THAT THE HANDPIECES WERE NOT BEING RECOGNIZED. THE U/S CONTROLLER PRINTED CIRCUIT BOARD (PCB) WAS REPLACED. THE SYSTEM WAS THEN TESTED AND FOUND TO MEET ALL PRODUCT SPECS. THE REP ALSO FOUND THAT ONE OF 3 HANDPIECES WAS NON FUNCTIONING. THE OTHER TWO HANDPIECES WERE ABLE TO PASS FUNCTIONAL TESTING. THE COMPANY REP NOTED THAT THE CUSTOMER WAS USING HANDPIECES THAT WERE REFURBISHED BY ANOTHER COMPANY. THE U/S CONTROLLER PCB IS EXPECTED TO RETURN FOR IN-HOUSE TESTING. A ROOT CAUSE HAS NOT BEEN IDENTIFIED. (B)(4).

Description of Event or Problem · 1

A CUSTOMER REPORTED DURING A CATARACT EXTRACTION PROCEDURE, THE HANDPIECE WAS NOT RECOGNIZED BY THE SYSTEM AND THERE WAS NO SUCTION DURING PHACOEMULSIFICATION. THE HANDPIECE WAS EXCHANGED BUT THE ISSUE CONTINUED. ANOTHER SYSTEM WAS USED TO COMPLETE THE SURGERY. IN A F/U, THE HEALTHCARE PROFESSIONAL REPORTED THE SYSTEM AND INITIAL HANDPIECE PRIMED SUCCESSFULLY BEFORE THE PROCEDURE. THE HANDPIECE(S) USED AS ALTERNATIVES WERE NOT RECOGNIZED BY THE SYSTEM. THE SURGERY WAS COMPLETED WITH ANOTHER SYSTEM USING AN ALTERNATIVE IRRIGATION AND ASPIRATION TECHNIQUE TO REMOVE THE CRYSTALLINE LENS. AS A RESULT, THE PROCEDURE WAS PROLONGED. THERE WAS NO HARM OR INJURY TO THE PT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFINITI VISION SYSTEM OZIL PHACOFRAGMENTATION SYSTEM HQC ALCON - IRVINE TECHNOLOGY CENTER INFINITI OZIL NA

Patients

Seq Age Sex Outcome Treatment
1